Yew Bio Pharm Cash Flow - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Aug 22, 2017 (Closing)

The Yew Bio Pharm cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Yew Bio Pharm profits one has to check the income statement and for Yew Bio Pharm debt one has to check the balance sheet. Yew Bio Pharm cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Yew Bio Pharm had cash and cash equivalents of $0.68M at the beginning of the quarter and $2.44M at quarter end for 2017-Q2.   Yew Bio Pharm has a positive cash and cash equivalents change of $2.16M. View details of Yew Bio Pharm cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Yew Bio Pharm Net Income Cash Flow
10.42M0.16M2M3.43M2.35M1.05M5.28M3.89M2.96M0.95M
Depreciation Depletion Amortization Cash-Flow0.12M0.05M8.93M8.87M8.87M5.02M7.74M1.22M0.33M0.16M
Net Increase (Decrease) in Assets Liabilities-10.6M-2.88M-12.82M-12.19M-11.16M-6.57M-15.43M-7.09M-5.41M-1.78M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.07M0.04M2.53M0.24M0.16M0.08M1.03M0.77M0.55M0.3M
Yew Bio Pharm Net Cash from (used by) Operating Activities
0.01M-2.61M0.64M0.36M0.22M-0.41M-1.37M-1.2M-1.57M-0.35M
Increase (Decrease) in Prop Plant And Equipment---0.06M-0.01M---0.02M-1.37M-0.59M-
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-0.68M-0.29M----2.33M---
Yew Bio Pharm Net Cash from (used by) Invesment Activities
-0.68M-0.23M-0.01M---2.36M-1.37M-0.59M-
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings2.88M2.88M-1.21M---3.21M1.64M1.64M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.08M-0.02M-0.04M-0.04M-0.03M-0.02M0.74M0.65M0.65M-
Yew Bio Pharm Net Cash from (used by) Financing Activities
2.81M2.86M-1.26M-0.04M-0.03M-0.02M3.96M2.29M2.29M-
Effect of Exchange Rate Changes on Cash0.02M-0.01M-0.01M-0.02M-0.01M--0.03M-0.03M--
Yew Bio Pharm Net Change in Cash & Cash Equivalents
2.16M0.24M-0.4M0.28M0.16M-0.44M0.19M-0.31M0.12M-0.35M
Cash & Equivalents at Beginning of Year0.68M0.48M1.15M0.38M0.73M1.85M----
Cash & Equivalents at Year End2.44M0.52M0.27M0.96M0.84M0.23M0.68M0.17M0.61M0.12M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Yew Bio Pharm stock comparison chart provides an easy way to compare the stock price with peers along with details of Yew Bio Pharm stock price history.
The statement of cash flows can be categorized into three main sections:
  • Yew Bio Pharm has cash of $2.44M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Yew Bio Pharm stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Yew Bio Pharm gained $2.62M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-0.68M for YEWB stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Yew Bio Pharm and its owners and creditors and was $2.81M for 2017-Q2. Financing activities allow a company to raise capital, and repay bondholders.
.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin
-0.33